123:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
es, viral proteins are produced and cleaved into active :@0.076190:0.084931:0.485130:0.084931:0.485130:0.069149:0.076190:0.069149:0.009827:0.005866:0.004188:0.004203:0.008376:0.003024:0.004551:0.010326:0.003024:0.004203:0.010311:0.004551:0.009903:0.005125:0.009827:0.003024:0.009223:0.005866:0.004203:0.010326:0.004551:0.009827:0.004203:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.009827:0.010357:0.004188:0.010326:0.009223:0.010357:0.004203:0.009782:0.003024:0.009827:0.010326:0.008376:0.009827:0.010357:0.004203:0.003024:0.009223:0.005125:0.009903:0.004188:0.010326:0.009782:0.005125:0.003024:0.008376:0.009827:0.004188
forms by the protease enzyme and are packaged into :@0.076190:0.099178:0.485130:0.099178:0.485130:0.083396:0.076190:0.083396:0.004747:0.009903:0.004551:0.014182:0.005866:0.004868:0.010311:0.008104:0.004883:0.005125:0.009223:0.009827:0.004868:0.010311:0.004551:0.009903:0.005125:0.009827:0.010326:0.005866:0.009827:0.004868:0.009827:0.009223:0.006426:0.008104:0.014182:0.009827:0.004868:0.010326:0.009223:0.010357:0.004883:0.010326:0.004551:0.009827:0.004883:0.010311:0.010326:0.009782:0.007590:0.010326:0.010175:0.009827:0.010357:0.004883:0.003024:0.009223:0.005125:0.009903:0.004188
new virions ready to infect more cells.:@0.076190:0.113425:0.350994:0.113425:0.350994:0.097643:0.076190:0.097643:0.009223:0.009827:0.012564:0.004188:0.008376:0.003024:0.004551:0.003024:0.009903:0.009223:0.005866:0.004188:0.004551:0.009827:0.010326:0.010357:0.008104:0.004188:0.005125:0.009903:0.004188:0.003024:0.009223:0.004747:0.009827:0.009782:0.005125:0.004188:0.014182:0.009903:0.004551:0.009827:0.004188:0.009782:0.009827:0.003024:0.003024:0.005866:0.004188
4:@0.350969:0.108135:0.355827:0.108135:0.355827:0.098981:0.350969:0.098981:0.004858
ClAsses Of AVAilAble AntiretrOVirAl :@0.076190:0.146432:0.436897:0.146432:0.436897:0.126267:0.076190:0.126267:0.014413:0.008131:0.013674:0.009609:0.009609:0.009609:0.009609:0.005174:0.015522:0.008870:0.005174:0.013674:0.012935:0.013674:0.005174:0.008131:0.013674:0.010718:0.008131:0.009609:0.005174:0.013674:0.013674:0.007761:0.005174:0.010718:0.009609:0.007761:0.010718:0.015522:0.012935:0.005174:0.010718:0.013674:0.008131:0.005174
DruGs :@0.076190:0.163253:0.141975:0.163253:0.141975:0.143088:0.076190:0.143088:0.012935:0.010718:0.011826:0.015522:0.009609:0.005174
The five classes of antiretroviral drugs that are available :@0.076190:0.179278:0.485130:0.179278:0.485130:0.163496:0.076190:0.163496:0.006441:0.009223:0.009827:0.004279:0.003681:0.003681:0.008376:0.009827:0.004294:0.009782:0.003024:0.010326:0.005866:0.005866:0.009827:0.005866:0.004309:0.009903:0.004747:0.004294:0.010326:0.009223:0.005125:0.003024:0.004551:0.009827:0.005125:0.004551:0.009903:0.008376:0.003024:0.004551:0.010326:0.003024:0.004279:0.010357:0.004551:0.009192:0.010175:0.005866:0.004294:0.005125:0.009223:0.010326:0.005125:0.004279:0.010326:0.004551:0.009827:0.004294:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188
include the nucleoside reverse transcriptase inhibitors :@0.076190:0.193525:0.485145:0.193525:0.485145:0.177743:0.076190:0.177743:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.007227:0.005125:0.009223:0.009827:0.007227:0.009223:0.009192:0.009782:0.003024:0.009827:0.009903:0.005866:0.003024:0.010357:0.009827:0.007227:0.004551:0.009827:0.008376:0.009827:0.004551:0.005866:0.009827:0.007227:0.005125:0.004551:0.010326:0.009223:0.005866:0.009782:0.004551:0.003024:0.010311:0.005125:0.010326:0.005866:0.009827:0.007227:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004188
(NRTIs), analogues that mimic normal building blocks :@0.076190:0.207772:0.485130:0.207772:0.485130:0.191990:0.076190:0.191990:0.005579:0.011188:0.009177:0.006441:0.003417:0.005866:0.005579:0.004188:0.007575:0.010326:0.009223:0.010326:0.003024:0.009903:0.010175:0.009192:0.009827:0.005866:0.007575:0.005125:0.009223:0.010326:0.005125:0.007575:0.014182:0.003024:0.014182:0.003024:0.009782:0.007575:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.007575:0.010311:0.009192:0.003024:0.003024:0.010357:0.003024:0.009223:0.010175:0.007575:0.010311:0.003024:0.009903:0.009782:0.007590:0.005866:0.004188
of DNA,  preventing  transcription of viral RNA  to DNA; :@0.076190:0.222019:0.485145:0.222019:0.485145:0.206237:0.076190:0.206237:0.009903:0.004747:0.006788:0.011249:0.011188:0.011188:0.004188:0.004188:0.002585:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.003024:0.009223:0.010175:0.004188:0.002585:0.005125:0.004551:0.010326:0.009223:0.005866:0.009782:0.004551:0.003024:0.010311:0.005125:0.003024:0.009903:0.009223:0.006788:0.009903:0.004747:0.006788:0.008376:0.003024:0.004551:0.010326:0.003024:0.006788:0.009177:0.011188:0.011188:0.004188:0.002585:0.005125:0.009903:0.006788:0.011249:0.011188:0.011188:0.004188:0.004188
non-nucleoside viral reverse transcriptase inhibitors (NN-:@0.076190:0.236267:0.480957:0.236267:0.480957:0.220484:0.076190:0.220484:0.009223:0.009903:0.009223:0.005020:0.009223:0.009192:0.009782:0.003024:0.009827:0.009903:0.005866:0.003024:0.010357:0.009827:0.003810:0.008376:0.003024:0.004551:0.010326:0.003024:0.003825:0.004551:0.009827:0.008376:0.009827:0.004551:0.005866:0.009827:0.003810:0.005125:0.004551:0.010326:0.009223:0.005866:0.009782:0.004551:0.003024:0.010311:0.005125:0.010326:0.005866:0.009827:0.003825:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.003825:0.005579:0.011188:0.011188:0.005020
RTIs),  that  fit  into  the  genomic  binding  site  of  reverse :@0.076190:0.250514:0.485130:0.250514:0.485130:0.234731:0.076190:0.234731:0.009177:0.006441:0.003417:0.005866:0.005579:0.004188:0.004188:0.002873:0.005125:0.009223:0.010326:0.005125:0.004188:0.002873:0.003681:0.003681:0.005125:0.004188:0.002873:0.003024:0.009223:0.005125:0.009903:0.004188:0.002873:0.005125:0.009223:0.009827:0.004188:0.002873:0.010175:0.009827:0.009223:0.009903:0.014167:0.003024:0.009782:0.004188:0.002888:0.010311:0.003024:0.009223:0.010357:0.003024:0.009223:0.010175:0.004188:0.002888:0.005866:0.003024:0.005125:0.009827:0.004188:0.002888:0.009903:0.004747:0.004188:0.002873:0.004551:0.009827:0.008376:0.009827:0.004551:0.005866:0.009827:0.004188
transcriptase and directly inhibit its action; protease :@0.076190:0.264761:0.485145:0.264761:0.485145:0.248978:0.076190:0.248978:0.005125:0.004551:0.010326:0.009223:0.005866:0.009782:0.004551:0.003024:0.010311:0.005125:0.010326:0.005866:0.009827:0.008814:0.010326:0.009223:0.010357:0.008814:0.010357:0.003024:0.004551:0.009827:0.009782:0.005125:0.003024:0.008104:0.008814:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.008814:0.003024:0.005125:0.005866:0.008814:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.008814:0.010311:0.004551:0.009903:0.005125:0.009827:0.010326:0.005866:0.009827:0.004188
inhibitors  (pIs) that  inhibit the  viral protease  enzyme, :@0.076190:0.279008:0.485145:0.279008:0.485145:0.263225:0.076190:0.263225:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.004188:0.004143:0.005579:0.008950:0.003417:0.005866:0.005579:0.008346:0.005125:0.009223:0.010326:0.005125:0.004188:0.004143:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.008346:0.005125:0.009223:0.009827:0.004188:0.004143:0.008376:0.003024:0.004551:0.010326:0.003024:0.008346:0.010311:0.004551:0.009903:0.005125:0.009827:0.010326:0.005866:0.009827:0.004188:0.004143:0.009827:0.009223:0.006426:0.008104:0.014182:0.009827:0.004188:0.004188
therefore  inhibiting  the  final  maturation  stages  of  HIV :@0.076190:0.293255:0.485130:0.293255:0.485130:0.277472:0.076190:0.277472:0.005125:0.009223:0.009827:0.004551:0.009827:0.004747:0.009903:0.004551:0.009827:0.004188:0.003009:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.003024:0.009223:0.010175:0.004188:0.003039:0.005125:0.009223:0.009827:0.004188:0.003024:0.003681:0.003681:0.009223:0.010326:0.003024:0.004188:0.003039:0.014182:0.010326:0.005125:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003024:0.005866:0.005125:0.010326:0.010175:0.009827:0.005866:0.004188:0.003039:0.009903:0.004747:0.004188:0.003024:0.010326:0.003417:0.010614:0.004188
replication, resulting in non-infective viral particles; entry :@0.076190:0.307502:0.485145:0.307502:0.485145:0.291719:0.076190:0.291719:0.004551:0.009827:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003613:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.003024:0.009223:0.010175:0.003613:0.003024:0.009223:0.003629:0.009223:0.009903:0.009223:0.005020:0.003024:0.009223:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.003613:0.008376:0.003024:0.004551:0.010326:0.003024:0.003629:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.003024:0.009827:0.005866:0.004188:0.003629:0.009827:0.009223:0.005125:0.004551:0.008104:0.004188
inhibitors that bind to the viral gp41, the host cell CD4 or :@0.076190:0.321749:0.485115:0.321749:0.485115:0.305966:0.076190:0.305966:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.003870:0.005125:0.009223:0.010326:0.005125:0.003855:0.010311:0.003024:0.009223:0.010357:0.003870:0.005125:0.009903:0.003855:0.005125:0.009223:0.009827:0.003855:0.008376:0.003024:0.004551:0.010326:0.003024:0.003870:0.010175:0.010311:0.008376:0.008376:0.004188:0.003870:0.005125:0.009223:0.009827:0.003855:0.009223:0.009903:0.005866:0.005125:0.003855:0.009782:0.009827:0.003024:0.003024:0.003870:0.012292:0.011249:0.008376:0.003870:0.009903:0.004551:0.004188
chemokine receptors and block the entry of the HIV into :@0.076190:0.335996:0.485145:0.335996:0.485145:0.320214:0.076190:0.320214:0.009782:0.009223:0.009827:0.014182:0.009903:0.007590:0.003024:0.009223:0.009827:0.003387:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.005866:0.003372:0.010326:0.009223:0.010357:0.003387:0.010311:0.003024:0.009903:0.009782:0.007590:0.003387:0.005125:0.009223:0.009827:0.003387:0.009827:0.009223:0.005125:0.004551:0.008104:0.003387:0.009903:0.004747:0.003387:0.005125:0.009223:0.009827:0.003387:0.010326:0.003417:0.010614:0.003387:0.003024:0.009223:0.005125:0.009903:0.004188
the host cell; and integrase inhibitors that block the viral :@0.076190:0.350243:0.485115:0.350243:0.485115:0.334461:0.076190:0.334461:0.005125:0.009223:0.009827:0.003946:0.009223:0.009903:0.005866:0.005125:0.003961:0.009782:0.009827:0.003024:0.003024:0.004188:0.003961:0.010326:0.009223:0.010357:0.003961:0.003024:0.009223:0.005125:0.009827:0.010175:0.004551:0.010326:0.005866:0.009827:0.003946:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.003961:0.005125:0.009223:0.010326:0.005125:0.003946:0.010311:0.003024:0.009903:0.009782:0.007590:0.003961:0.005125:0.009223:0.009827:0.003946:0.008376:0.003024:0.004551:0.010326:0.003024:0.004188
DNA integration into the host cell genome.  The drugs :@0.076190:0.364490:0.485137:0.364544:0.485137:0.348761:0.076190:0.348708:0.011249:0.011188:0.011188:0.005821:0.003024:0.009223:0.005125:0.009827:0.010175:0.004551:0.010326:0.005125:0.003024:0.009888:0.009223:0.005821:0.003024:0.009223:0.005125:0.009903:0.005821:0.005125:0.009223:0.009827:0.005821:0.009223:0.009903:0.005866:0.005125:0.005821:0.009782:0.009827:0.003024:0.003024:0.005836:0.010175:0.009827:0.009223:0.009903:0.014182:0.009827:0.004188:0.004860:0.005821:0.006441:0.009223:0.009827:0.005821:0.010357:0.004551:0.009192:0.010175:0.005866:0.371864
5:@0.398816:0.359245:0.403674:0.359245:0.403674:0.350091:0.398816:0.350091:0.004858
available in south Africa by class are listed in Table 1.:@0.076197:0.378791:0.463426:0.378791:0.463426:0.363008:0.076197:0.363008:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188:0.003024:0.009223:0.004188:0.007529:0.009903:0.009192:0.005125:0.009223:0.004188:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188:0.010311:0.008104:0.004188:0.009782:0.003024:0.010326:0.005866:0.005866:0.004188:0.010326:0.004551:0.009827:0.004188:0.003024:0.003024:0.005866:0.005125:0.009827:0.010357:0.004188:0.003024:0.009223:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.004188:0.008376:0.004188
mAnAGement:@0.076190:0.411793:0.206651:0.411793:0.206651:0.391629:0.076190:0.391629:0.016631:0.013674:0.013674:0.013674:0.015522:0.009609:0.016631:0.009609:0.013674:0.007761
Counselling:@0.076190:0.437196:0.171608:0.437196:0.171608:0.418865:0.076190:0.418865:0.013103:0.010751:0.010079:0.010079:0.007392:0.010751:0.004032:0.004032:0.004032:0.010079:0.011087
In addition to pre- and post-test counselling for HIV-:@0.076190:0.453619:0.480957:0.453619:0.480957:0.437837:0.076190:0.437837:0.003417:0.009223:0.007892:0.010326:0.010357:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.007892:0.005125:0.009903:0.007892:0.010311:0.004551:0.009827:0.005020:0.007892:0.010326:0.009223:0.010357:0.007892:0.010311:0.009903:0.005866:0.005125:0.005020:0.005125:0.009827:0.005866:0.005125:0.007892:0.009782:0.009903:0.009192:0.009223:0.005866:0.009827:0.003024:0.003024:0.003024:0.009223:0.010175:0.007892:0.004747:0.009903:0.004551:0.007892:0.010326:0.003417:0.010614:0.005020
testing, patients should receive adherence to therapy :@0.076190:0.467866:0.485130:0.467866:0.485130:0.452084:0.076190:0.452084:0.005125:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175:0.004188:0.005851:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005866:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005866:0.004551:0.009827:0.009782:0.009827:0.003024:0.008376:0.009827:0.005866:0.010326:0.010357:0.009223:0.009827:0.004551:0.009827:0.009223:0.009782:0.009827:0.005851:0.005125:0.009903:0.005851:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188
counselling and screening for opportunistic infections :@0.076190:0.482114:0.485145:0.482114:0.485145:0.466331:0.076190:0.466331:0.009782:0.009903:0.009192:0.009223:0.005866:0.009827:0.003024:0.003024:0.003024:0.009223:0.010175:0.007363:0.010326:0.009223:0.010357:0.007363:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.003024:0.009223:0.010175:0.007363:0.004747:0.009903:0.004551:0.007363:0.009903:0.010311:0.010311:0.009903:0.004551:0.005125:0.009192:0.009223:0.003024:0.005866:0.005125:0.003024:0.009782:0.007363:0.003024:0.009223:0.004747:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
prior to initiation of therapy. The patient should be :@0.076190:0.496361:0.485130:0.496361:0.485130:0.480578:0.076190:0.480578:0.010311:0.004551:0.003024:0.009903:0.004551:0.009238:0.005125:0.009903:0.009238:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.009238:0.009903:0.004747:0.009238:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.009238:0.006441:0.009223:0.009827:0.009238:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.009238:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.009238:0.010311:0.009827:0.004188
taught the names of the drugs, how often they should :@0.076190:0.510608:0.485130:0.510608:0.485130:0.494825:0.076190:0.494825:0.005125:0.010326:0.009192:0.010175:0.009223:0.005125:0.005382:0.005125:0.009223:0.009827:0.005382:0.009223:0.010326:0.014182:0.009827:0.005866:0.005397:0.009903:0.004747:0.005382:0.005125:0.009223:0.009827:0.005382:0.010357:0.004551:0.009192:0.010175:0.005866:0.004188:0.005397:0.009223:0.009903:0.012564:0.005382:0.009903:0.004747:0.005125:0.009827:0.009223:0.005382:0.005125:0.009223:0.009827:0.008104:0.005382:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004188
be taken and their side  effects, which are generally :@0.076190:0.524855:0.485145:0.524855:0.485145:0.509072:0.076190:0.509072:0.010311:0.009827:0.007635:0.005125:0.010326:0.007590:0.009827:0.009223:0.007635:0.010326:0.009223:0.010357:0.007635:0.005125:0.009223:0.009827:0.003024:0.004551:0.007635:0.005866:0.003024:0.010357:0.009827:0.004188:0.003462:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.007635:0.012564:0.009223:0.003024:0.009782:0.009223:0.007635:0.010326:0.004551:0.009827:0.007635:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.003024:0.008104:0.004188
transient and mild (see Tables 1 and 2).  :@0.076190:0.539102:0.377942:0.539126:0.377942:0.523344:0.076190:0.523319:0.005125:0.004551:0.010326:0.009223:0.005866:0.003024:0.009827:0.009223:0.005125:0.004188:0.010326:0.009223:0.010357:0.004188:0.014182:0.003024:0.003024:0.010357:0.004188:0.005579:0.005866:0.009827:0.009827:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.005866:0.004188:0.008376:0.004188:0.010326:0.009223:0.010357:0.004188:0.008376:0.005579:0.004188:0.012146:0.250439
5,6:@0.361607:0.533828:0.373752:0.533828:0.373752:0.524674:0.361607:0.524674:0.004858:0.002429:0.004858
inVestiGAtiOns:@0.076190:0.572125:0.221064:0.572125:0.221064:0.551960:0.076190:0.551960:0.005174:0.013674:0.012935:0.009609:0.009609:0.007761:0.005174:0.015522:0.013674:0.007761:0.005174:0.015522:0.013674:0.009609
Diagnosis of HiV infection:@0.076190:0.588154:0.266887:0.588154:0.266887:0.571656:0.076190:0.571656:0.010583:0.003629:0.009979:0.009979:0.009071:0.009676:0.006652:0.003629:0.006652:0.006214:0.009676:0.004233:0.006214:0.010281:0.004233:0.010583:0.006214:0.003629:0.009071:0.004233:0.009676:0.009676:0.004536:0.003629:0.009676:0.009071
 - The laboratory diagnosis is :@0.266887:0.588154:0.485115:0.588154:0.485115:0.572371:0.266887:0.572371:0.006153:0.005020:0.006153:0.006441:0.009223:0.009827:0.006138:0.003024:0.010326:0.010311:0.009903:0.004551:0.010326:0.005125:0.009903:0.004551:0.008104:0.006153:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.006153:0.003024:0.005866:0.004188
dependent on the detection of HIV antigen and its anti-:@0.076190:0.602401:0.480942:0.602401:0.480942:0.586619:0.076190:0.586619:0.010357:0.009827:0.010311:0.009827:0.009223:0.010357:0.009827:0.009223:0.005125:0.003613:0.009903:0.009223:0.003629:0.005125:0.009223:0.009827:0.003613:0.010357:0.009827:0.005125:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.003613:0.009903:0.004747:0.003629:0.010326:0.003417:0.010614:0.003629:0.010326:0.009223:0.005125:0.003024:0.010175:0.009827:0.009223:0.003629:0.010326:0.009223:0.010357:0.003629:0.003024:0.005125:0.005866:0.003629:0.010326:0.009223:0.005125:0.003024:0.005020
bodies. This is helpful in terms of shortening the window :@0.519042:0.084923:0.927982:0.084923:0.927982:0.069140:0.519042:0.069140:0.010311:0.009903:0.010357:0.003024:0.009827:0.005866:0.004188:0.004899:0.006441:0.009223:0.003024:0.005866:0.004899:0.003024:0.005866:0.004914:0.009223:0.009827:0.003024:0.010311:0.004747:0.009192:0.003024:0.004899:0.003024:0.009223:0.004899:0.005125:0.009827:0.004551:0.014182:0.005866:0.004899:0.009903:0.004747:0.004899:0.005866:0.009223:0.009903:0.004551:0.005125:0.009827:0.009223:0.003024:0.009223:0.010175:0.004883:0.005125:0.009223:0.009827:0.004899:0.012564:0.003024:0.009223:0.010357:0.009903:0.012564:0.004188
period, which is defined as the time between HIV infec:@0.519042:0.099124:0.918774:0.099124:0.918774:0.083341:0.519042:0.083341:0.010311:0.009827:0.004551:0.003024:0.009903:0.010357:0.004188:0.004188:0.012564:0.009223:0.003024:0.009782:0.009223:0.004188:0.003024:0.005866:0.004188:0.010357:0.009827:0.003681:0.003681:0.009223:0.009827:0.010357:0.004188:0.010326:0.005866:0.004203:0.005125:0.009223:0.009827:0.004188:0.005125:0.003024:0.014182:0.009827:0.004188:0.010311:0.009827:0.005125:0.012564:0.009827:0.009827:0.009223:0.004188:0.010326:0.003417:0.010614:0.004203:0.003024:0.009223:0.004747:0.009827:0.009782
-:@0.918774:0.099124:0.923794:0.099124:0.923794:0.083341:0.918774:0.083341:0.005020
tion and appearance of antibodies to HIV, as HIV anti-:@0.519042:0.113324:0.923794:0.113324:0.923794:0.097542:0.519042:0.097542:0.005125:0.003024:0.009903:0.009223:0.004914:0.010326:0.009223:0.010357:0.004914:0.010326:0.010311:0.010311:0.009827:0.010326:0.004551:0.010326:0.009223:0.009782:0.009827:0.004914:0.009903:0.004747:0.004914:0.010326:0.009223:0.005125:0.003024:0.010311:0.009903:0.010357:0.003024:0.009827:0.005866:0.004929:0.005125:0.009903:0.004914:0.010326:0.003417:0.010614:0.004188:0.004929:0.010326:0.005866:0.004929:0.010326:0.003417:0.010614:0.004929:0.010326:0.009223:0.005125:0.003024:0.005020
gen is present in the blood much earlier than antibodies :@0.519042:0.127525:0.927997:0.127525:0.927997:0.111743:0.519042:0.111743:0.010175:0.009827:0.009223:0.003734:0.003024:0.005866:0.003734:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.003734:0.003024:0.009223:0.003734:0.005125:0.009223:0.009827:0.003734:0.010311:0.003024:0.009903:0.009903:0.010357:0.003734:0.014182:0.009192:0.009782:0.009223:0.003734:0.009827:0.010326:0.004551:0.003024:0.003024:0.009827:0.004551:0.003734:0.005125:0.009223:0.010326:0.009223:0.003734:0.010326:0.009223:0.005125:0.003024:0.010311:0.009903:0.010357:0.003024:0.009827:0.005866:0.004188
to HIV can be detected. A fourth-generation ELIsA test :@0.519042:0.141726:0.927997:0.141726:0.927997:0.125944:0.519042:0.125944:0.005125:0.009903:0.004778:0.010326:0.003417:0.010614:0.004778:0.009782:0.010326:0.009223:0.004778:0.010311:0.009827:0.004778:0.010357:0.009827:0.005125:0.009827:0.009782:0.005125:0.009827:0.010357:0.004188:0.004762:0.011188:0.004778:0.004747:0.009903:0.009192:0.004551:0.005125:0.009223:0.005020:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004747:0.008104:0.006985:0.003417:0.007529:0.011188:0.004778:0.005125:0.009827:0.005866:0.005125:0.004188
that is able to detect both the antigen and antibody in :@0.519042:0.155927:0.927982:0.155927:0.927982:0.140145:0.519042:0.140145:0.005125:0.009223:0.010326:0.005125:0.004324:0.003024:0.005866:0.004339:0.010326:0.010311:0.003024:0.009827:0.004339:0.005125:0.009903:0.004324:0.010357:0.009827:0.005125:0.009827:0.009782:0.005125:0.004324:0.010311:0.009903:0.005125:0.009223:0.004324:0.005125:0.009223:0.009827:0.004339:0.010326:0.009223:0.005125:0.003024:0.010175:0.009827:0.009223:0.004324:0.010326:0.009223:0.010357:0.004339:0.010326:0.009223:0.005125:0.003024:0.010311:0.009903:0.010357:0.008104:0.004339:0.003024:0.009223:0.004188
one test is available in most south African laboratories.:@0.519042:0.170128:0.916960:0.170128:0.916960:0.154345:0.519042:0.154345:0.009903:0.009223:0.009827:0.004188:0.005125:0.009827:0.005866:0.005125:0.004188:0.003024:0.005866:0.004188:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188:0.003024:0.009223:0.004188:0.014182:0.009903:0.005866:0.005125:0.004188:0.007529:0.009903:0.009192:0.005125:0.009223:0.004188:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.009223:0.004188:0.003024:0.010326:0.010311:0.009903:0.004551:0.010326:0.005125:0.009903:0.004551:0.003024:0.009827:0.005866:0.004188
baseline investigations prior to Art initiation:@0.533330:0.184329:0.861866:0.184329:0.861866:0.167831:0.533330:0.167831:0.008769:0.009979:0.006652:0.009676:0.003629:0.003629:0.009071:0.009676:0.006683:0.003629:0.009071:0.008467:0.009676:0.006652:0.004536:0.003629:0.009979:0.009979:0.004536:0.003629:0.009676:0.009071:0.006652:0.006683:0.009979:0.004838:0.003629:0.009676:0.004838:0.006683:0.004536:0.009676:0.006683:0.011188:0.008769:0.006350:0.006683:0.003629:0.009071:0.003629:0.004536:0.003629:0.009979:0.004536:0.003629:0.009676:0.009071
  –  These :@0.861836:0.184329:0.927982:0.184329:0.927982:0.168546:0.861836:0.168546:0.004188:0.002419:0.007560:0.004188:0.002419:0.006441:0.009223:0.009827:0.005866:0.009827:0.004188
must include a full blood count (FBC), a liver-function :@0.519042:0.198530:0.927997:0.198530:0.927997:0.182747:0.519042:0.182747:0.014182:0.009192:0.005866:0.005125:0.006365:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.006365:0.010326:0.006365:0.004747:0.009192:0.003024:0.003024:0.006365:0.010311:0.003024:0.009903:0.009903:0.010357:0.006365:0.009782:0.009903:0.009192:0.009223:0.005125:0.006365:0.005579:0.007333:0.008678:0.012292:0.005579:0.004188:0.006365:0.010326:0.006365:0.003024:0.003024:0.008376:0.009827:0.004551:0.005020:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
test,  a serum  creatinine,  a urinalysis for  proteinuria,  a :@0.519042:0.212731:0.927982:0.212731:0.927982:0.196948:0.519042:0.196948:0.005125:0.009827:0.005866:0.005125:0.004188:0.004188:0.002963:0.010326:0.007166:0.005866:0.009827:0.004551:0.009192:0.014182:0.004188:0.002963:0.009782:0.004551:0.009827:0.010326:0.005125:0.003024:0.009223:0.003024:0.009223:0.009827:0.004188:0.004188:0.002963:0.010326:0.007166:0.009192:0.004551:0.003024:0.009223:0.010326:0.003024:0.008104:0.005866:0.003024:0.005866:0.007166:0.004747:0.009903:0.004551:0.004188:0.002963:0.010311:0.004551:0.009903:0.005125:0.009827:0.003024:0.009223:0.009192:0.004551:0.003024:0.010326:0.004188:0.004188:0.002963:0.010326:0.004188
hepatitis B surface antigen, a CD4 count,  a HIV viral :@0.519042:0.226932:0.927967:0.226932:0.927967:0.211149:0.519042:0.211149:0.009223:0.009827:0.010311:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.007242:0.008678:0.007242:0.005866:0.009192:0.004551:0.004747:0.010326:0.009782:0.009827:0.007242:0.010326:0.009223:0.005125:0.003024:0.010175:0.009827:0.009223:0.004188:0.007242:0.010326:0.007242:0.012292:0.011249:0.008376:0.007242:0.009782:0.009903:0.009192:0.009223:0.005125:0.004188:0.004188:0.003039:0.010326:0.007242:0.010326:0.003417:0.010614:0.007242:0.008376:0.003024:0.004551:0.010326:0.003024:0.004188
load and a serum cryptococcal antigen test.:@0.519042:0.241133:0.849060:0.241133:0.849060:0.225350:0.519042:0.225350:0.003024:0.009903:0.010326:0.010357:0.004188:0.010326:0.009223:0.010357:0.004188:0.010326:0.004188:0.005866:0.009827:0.004551:0.009192:0.014182:0.004188:0.009782:0.004551:0.008104:0.010311:0.005125:0.009903:0.009782:0.009903:0.009782:0.009782:0.010326:0.003024:0.004188:0.010326:0.009223:0.005125:0.003024:0.010175:0.009827:0.009223:0.004188:0.005125:0.009827:0.005866:0.005125:0.004188
5,6:@0.849038:0.235817:0.861183:0.235817:0.861183:0.226663:0.849038:0.226663:0.004858:0.002429:0.004858
laboratory monitoring on Art :@0.533333:0.255314:0.751274:0.255314:0.751274:0.238815:0.533333:0.238815:0.006501:0.009827:0.009827:0.009525:0.004687:0.009827:0.004385:0.009525:0.004687:0.008618:0.005065:0.014061:0.009525:0.008920:0.003477:0.004385:0.009525:0.004687:0.003477:0.008920:0.009827:0.005065:0.009525:0.008920:0.005065:0.011037:0.008618:0.006199:0.004233
– In order to monitor for :@0.752121:0.255314:0.928061:0.255314:0.928061:0.239531:0.752121:0.239531:0.007408:0.005020:0.003266:0.009071:0.005020:0.009752:0.004400:0.010205:0.009676:0.004400:0.005020:0.004974:0.009752:0.005020:0.014030:0.009752:0.009071:0.002873:0.004974:0.009752:0.004400:0.005020:0.004596:0.009752:0.004551:0.004188
antiviral  therapy  efficacy,  CD4  counts  should  be  per:@0.519045:0.269515:0.918929:0.269515:0.918929:0.253732:0.519045:0.253732:0.010175:0.009071:0.004974:0.002873:0.008225:0.002873:0.004400:0.010175:0.002873:0.004188:0.003583:0.004974:0.009071:0.009676:0.004400:0.010175:0.010160:0.007953:0.004188:0.003583:0.009676:0.004596:0.003606:0.003606:0.009631:0.010175:0.009631:0.007953:0.004037:0.004188:0.003583:0.012141:0.011097:0.008225:0.004188:0.003583:0.009631:0.009752:0.009041:0.009071:0.004974:0.005715:0.004188:0.003583:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.004188:0.003583:0.010160:0.009676:0.004188:0.003583:0.010160:0.009676:0.004551
-:@0.918778:0.269515:0.923797:0.269515:0.923797:0.253732:0.918778:0.253732:0.005020
formed every six months. Viral loads should be performed :@0.519045:0.283716:0.927985:0.283716:0.927985:0.267933:0.519045:0.267933:0.004596:0.009752:0.004400:0.014030:0.009676:0.010205:0.003356:0.009676:0.008225:0.009676:0.004400:0.007953:0.003341:0.005715:0.002873:0.007106:0.003341:0.014030:0.009752:0.009071:0.004974:0.009071:0.005715:0.004037:0.003341:0.010462:0.002873:0.004400:0.010175:0.002873:0.003356:0.002873:0.009752:0.010175:0.010205:0.005715:0.003341:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.003341:0.010160:0.009676:0.003356:0.010160:0.009676:0.004400:0.004596:0.009752:0.004400:0.014030:0.009676:0.010357:0.004188
at three months, repeated at six months and then every :@0.519045:0.297917:0.927970:0.297917:0.927970:0.282134:0.519045:0.282134:0.010175:0.004974:0.004490:0.004974:0.009071:0.004400:0.009676:0.009676:0.004490:0.014030:0.009752:0.009071:0.004974:0.009071:0.005715:0.004037:0.004490:0.004400:0.009676:0.010160:0.009676:0.010175:0.004974:0.009676:0.010205:0.004490:0.010175:0.004974:0.004490:0.005715:0.002873:0.007106:0.004490:0.014030:0.009752:0.009071:0.004974:0.009071:0.005715:0.004490:0.010175:0.009071:0.010205:0.004490:0.004974:0.009071:0.009676:0.009071:0.004490:0.009676:0.008225:0.009676:0.004400:0.008104:0.004188
six months thereafter. A good indication of a response to :@0.519045:0.312117:0.928000:0.312117:0.928000:0.296335:0.519045:0.296335:0.005715:0.002873:0.007106:0.003886:0.014030:0.009752:0.009071:0.004974:0.009071:0.005715:0.003886:0.004974:0.009071:0.009676:0.004400:0.009676:0.010175:0.004596:0.004974:0.009676:0.004400:0.004037:0.003886:0.011037:0.003886:0.010024:0.009752:0.009752:0.010205:0.003886:0.002873:0.009071:0.010205:0.002873:0.009631:0.010175:0.004974:0.002873:0.009752:0.009071:0.003886:0.009752:0.004596:0.003886:0.010175:0.003886:0.004400:0.009676:0.005715:0.010160:0.009752:0.009071:0.005715:0.009676:0.003886:0.004974:0.009903:0.004188
ART includes a suppression of the viral load to <50 cop:@0.519045:0.326318:0.918899:0.326318:0.918899:0.310536:0.519045:0.310536:0.011037:0.009026:0.006290:0.005246:0.002873:0.009071:0.009631:0.002873:0.009041:0.010205:0.009676:0.005715:0.005246:0.010175:0.005246:0.005715:0.009041:0.010160:0.010160:0.004400:0.009676:0.005715:0.005715:0.002873:0.009752:0.009071:0.005246:0.009752:0.004596:0.005246:0.004974:0.009071:0.009676:0.005246:0.008225:0.002873:0.004400:0.010175:0.002873:0.005246:0.002873:0.009752:0.010175:0.010205:0.005246:0.004974:0.009752:0.005246:0.009011:0.008225:0.008225:0.005246:0.009631:0.009752:0.010311
-:@0.918747:0.326318:0.923767:0.326318:0.923767:0.310536:0.918747:0.310536:0.005020
ies/ml or >2 log drop from baseline in those patients with :@0.519045:0.340519:0.928031:0.340519:0.928031:0.324737:0.519045:0.324737:0.002873:0.009676:0.005715:0.006456:0.014030:0.002873:0.004339:0.009752:0.004400:0.004339:0.009011:0.008225:0.004339:0.002873:0.009752:0.010024:0.004339:0.010205:0.004400:0.009752:0.010160:0.004339:0.004596:0.004400:0.009752:0.014030:0.004339:0.010160:0.010175:0.005715:0.009676:0.002873:0.002873:0.009071:0.009676:0.004339:0.002873:0.009071:0.004339:0.004974:0.009071:0.009752:0.005715:0.009676:0.004339:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.005715:0.004339:0.012413:0.002873:0.004974:0.009223:0.004188
a very high viral load at baseline. A FBC should be per-:@0.519045:0.354720:0.923812:0.354720:0.923812:0.338938:0.519045:0.338938:0.010175:0.005246:0.008225:0.009676:0.004400:0.007953:0.005246:0.009071:0.002873:0.010024:0.009071:0.005246:0.008225:0.002873:0.004400:0.010175:0.002873:0.005246:0.002873:0.009752:0.010175:0.010205:0.005246:0.010175:0.004974:0.005246:0.010160:0.010175:0.005715:0.009676:0.002873:0.002873:0.009071:0.009676:0.004037:0.005246:0.011037:0.005246:0.007182:0.008527:0.012141:0.005246:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.005246:0.010160:0.009676:0.005246:0.010160:0.009676:0.004400:0.005020
formed monthly for three months, then after six months :@0.519045:0.368921:0.928091:0.368921:0.928091:0.353138:0.519045:0.353138:0.004596:0.009752:0.004400:0.014030:0.009676:0.010205:0.005775:0.014030:0.009752:0.009071:0.004974:0.009071:0.002873:0.007953:0.005775:0.004596:0.009752:0.004400:0.005775:0.004974:0.009071:0.004400:0.009676:0.009676:0.005775:0.014030:0.009752:0.009071:0.004974:0.009071:0.005715:0.004037:0.005775:0.004974:0.009071:0.009676:0.009071:0.005775:0.010175:0.004596:0.004974:0.009676:0.004400:0.005775:0.005715:0.002873:0.007106:0.005775:0.014030:0.009752:0.009071:0.004974:0.009071:0.005866:0.004188
on zidovudine (AZT) and thereafter when clinically indi-:@0.519045:0.383122:0.923843:0.383122:0.923843:0.367339:0.519045:0.367339:0.009752:0.009071:0.005760:0.006274:0.002873:0.010205:0.009752:0.008225:0.009041:0.010205:0.002873:0.009071:0.009676:0.005760:0.005428:0.011037:0.007106:0.006290:0.005428:0.005760:0.010175:0.009071:0.010205:0.005760:0.004974:0.009071:0.009676:0.004400:0.009676:0.010175:0.004596:0.004974:0.009676:0.004400:0.005760:0.012413:0.009071:0.009676:0.009071:0.005760:0.009631:0.002873:0.002873:0.009071:0.002873:0.009631:0.010175:0.002873:0.002873:0.007953:0.005760:0.002873:0.009071:0.010205:0.002873:0.005020
cated. A serum creatinine should be performed at three :@0.519045:0.397323:0.928000:0.397323:0.928000:0.381540:0.519045:0.381540:0.009631:0.010175:0.004974:0.009676:0.010205:0.004037:0.004158:0.011037:0.004158:0.005715:0.009676:0.004400:0.009041:0.014030:0.004158:0.009631:0.004400:0.009676:0.010175:0.004974:0.002873:0.009071:0.002873:0.009071:0.009676:0.004158:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.004158:0.010160:0.009676:0.004158:0.010160:0.009676:0.004400:0.004596:0.009752:0.004400:0.014030:0.009676:0.010205:0.004158:0.010175:0.004974:0.004158:0.004974:0.009071:0.004400:0.009676:0.009827:0.004188
months, six months, one year, and then every 12 months :@0.519045:0.411524:0.928000:0.411524:0.928000:0.395741:0.519045:0.395741:0.014030:0.009752:0.009071:0.004974:0.009071:0.005715:0.004037:0.004400:0.005715:0.002873:0.007106:0.004415:0.014030:0.009752:0.009071:0.004974:0.009071:0.005715:0.004037:0.004415:0.009752:0.009071:0.009676:0.004400:0.007953:0.009676:0.010175:0.004400:0.004037:0.004400:0.010175:0.009071:0.010205:0.004400:0.004974:0.009071:0.009676:0.009071:0.004400:0.009676:0.008225:0.009676:0.004400:0.007953:0.004415:0.008225:0.008225:0.004400:0.014030:0.009752:0.009071:0.004974:0.009071:0.005866:0.004188
if on tenofovir (TDF). Fasting cholesterol and triglycerides :@0.519045:0.425725:0.927970:0.425725:0.927970:0.409942:0.519045:0.409942:0.002873:0.004596:0.004626:0.009752:0.009071:0.004626:0.004974:0.009676:0.009071:0.009752:0.004596:0.009752:0.008225:0.002873:0.004400:0.004626:0.005428:0.006290:0.011097:0.007182:0.005428:0.004037:0.004626:0.007182:0.010175:0.005715:0.004974:0.002873:0.009071:0.010024:0.004626:0.009631:0.009071:0.009752:0.002873:0.009676:0.005715:0.004974:0.009676:0.004400:0.009752:0.002873:0.004626:0.010175:0.009071:0.010205:0.004626:0.004974:0.004400:0.002873:0.010024:0.002873:0.007953:0.009631:0.009676:0.004400:0.002873:0.010205:0.009676:0.005866:0.004188
should be performed at three months if on lopinavir/rito-:@0.519045:0.439926:0.923843:0.439926:0.923843:0.424143:0.519045:0.424143:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.004460:0.010160:0.009676:0.004460:0.010160:0.009676:0.004400:0.004596:0.009752:0.004400:0.014030:0.009676:0.010205:0.004460:0.010175:0.004974:0.004460:0.004974:0.009071:0.004400:0.009676:0.009676:0.004460:0.014030:0.009752:0.009071:0.004974:0.009071:0.005715:0.004460:0.002873:0.004596:0.004460:0.009752:0.009071:0.004460:0.002873:0.009752:0.010160:0.002873:0.009071:0.010175:0.008225:0.002873:0.004400:0.006456:0.004400:0.002873:0.004974:0.009752:0.005020
navir (LpV/r), then annually only in those with other car-:@0.519045:0.454126:0.923812:0.454126:0.923812:0.438344:0.519045:0.438344:0.009071:0.010175:0.008225:0.002873:0.004400:0.005216:0.005428:0.006834:0.008799:0.010462:0.006456:0.004400:0.005428:0.004037:0.005216:0.004974:0.009071:0.009676:0.009071:0.005216:0.010175:0.009071:0.009071:0.009041:0.010175:0.002873:0.002873:0.007953:0.005216:0.009752:0.009071:0.002873:0.007953:0.005216:0.002873:0.009071:0.005216:0.004974:0.009071:0.009752:0.005715:0.009676:0.005216:0.012413:0.002873:0.004974:0.009071:0.005216:0.009752:0.004974:0.009071:0.009676:0.004400:0.005216:0.009631:0.010175:0.004400:0.005020
diovascular-risk factors.  Other serum biochemical tests :@0.519045:0.468327:0.928004:0.468292:0.928004:0.452509:0.519045:0.452545:0.010205:0.002873:0.009752:0.008225:0.010175:0.005715:0.009631:0.009041:0.002873:0.010175:0.004400:0.004868:0.004400:0.002873:0.005715:0.007439:0.005065:0.004596:0.010175:0.009631:0.004974:0.009752:0.004400:0.005715:0.004188:0.011737:0.005065:0.012987:0.004974:0.009071:0.009676:0.004400:0.005065:0.005715:0.009676:0.004400:0.009041:0.014030:0.005065:0.010160:0.002873:0.009752:0.009631:0.009071:0.009676:0.014030:0.002873:0.009631:0.010175:0.002873:0.005065:0.004974:0.009676:0.005715:0.004974:0.005866:-0.206864
5,6:@0.685751:0.462993:0.697721:0.462993:0.697721:0.453839:0.685751:0.453839:0.004770:0.002341:0.004858
should be carried out as clinically indicated.:@0.519050:0.482493:0.835476:0.482493:0.835476:0.466710:0.519050:0.466710:0.005715:0.009071:0.009752:0.009041:0.002873:0.010205:0.004037:0.010160:0.009676:0.004037:0.009631:0.010175:0.004400:0.004400:0.002873:0.009676:0.010205:0.004037:0.009752:0.009041:0.004974:0.004037:0.010175:0.005715:0.004037:0.009631:0.002873:0.002873:0.009071:0.002873:0.009631:0.010175:0.002873:0.002873:0.007953:0.004037:0.002873:0.009071:0.010205:0.002873:0.009631:0.010175:0.004974:0.009676:0.010205:0.004188
inDiCAtiOns fOr Art :@0.519047:0.515436:0.718619:0.515436:0.718619:0.495271:0.519047:0.495271:0.005174:0.013674:0.012935:0.005174:0.014413:0.013674:0.007761:0.005174:0.015522:0.013674:0.009609:0.005174:0.008870:0.015522:0.010718:0.005174:0.013674:0.010718:0.007761:0.005174
The goals of ART are to suppress viral load, restore im-:@0.519047:0.531413:0.923814:0.531413:0.923814:0.515630:0.519047:0.515630:0.006441:0.009223:0.009827:0.005791:0.010175:0.009903:0.010326:0.003024:0.005866:0.005806:0.009903:0.004747:0.005806:0.011188:0.009177:0.006441:0.005806:0.010326:0.004551:0.009827:0.005806:0.005125:0.009903:0.005806:0.005866:0.009192:0.010311:0.010311:0.004551:0.009827:0.005866:0.005866:0.005806:0.008376:0.003024:0.004551:0.010326:0.003024:0.005806:0.003024:0.009903:0.010326:0.010357:0.004188:0.005806:0.004551:0.009827:0.005866:0.005125:0.009903:0.004551:0.009827:0.005791:0.003024:0.014182:0.005020
mune  function,  reduce  morbidity  and  mortality,  and :@0.519047:0.545614:0.927972:0.545614:0.927972:0.529831:0.519047:0.529831:0.014182:0.009192:0.009223:0.009827:0.004188:0.003886:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009207:0.004188:0.004188:0.003886:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.004188:0.003886:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005125:0.008104:0.004188:0.003886:0.010326:0.009223:0.010357:0.004188:0.003886:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.004188:0.003886:0.010326:0.009223:0.010357:0.004188
prevent onward transmission of HIV.:@0.519047:0.559815:0.779337:0.559815:0.779337:0.544032:0.519047:0.544032:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.004188:0.009903:0.009223:0.012564:0.010326:0.004551:0.010357:0.004188:0.005125:0.004551:0.010326:0.009223:0.005866:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.004188:0.009903:0.004747:0.004188:0.010326:0.003417:0.010614:0.004188
5:@0.779319:0.554511:0.784177:0.554511:0.784177:0.545357:0.779319:0.545357:0.004858
Early initiation of antiretroviral therapy is now widely :@0.533333:0.574008:0.927985:0.574008:0.927985:0.558226:0.533333:0.558226:0.008104:0.010326:0.004551:0.003024:0.008104:0.006410:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.006395:0.009903:0.004747:0.006395:0.010326:0.009223:0.005125:0.003024:0.004551:0.009827:0.005125:0.004551:0.009903:0.008376:0.003024:0.004551:0.010311:0.003024:0.006395:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.006395:0.003024:0.005866:0.006410:0.009223:0.009903:0.012564:0.006395:0.012564:0.003024:0.010357:0.009827:0.003024:0.008104:0.004188
recommended and supported by high-quality clinical :@0.519045:0.588209:0.927985:0.588209:0.927985:0.572427:0.519045:0.572427:0.004551:0.009827:0.009782:0.009903:0.014182:0.014182:0.009827:0.009223:0.010357:0.009827:0.010357:0.006380:0.010326:0.009223:0.010357:0.006395:0.005866:0.009192:0.010311:0.010311:0.009903:0.004551:0.005125:0.009827:0.010357:0.006395:0.010311:0.008104:0.006410:0.009223:0.003024:0.010175:0.009223:0.005020:0.010311:0.009192:0.010326:0.003024:0.003024:0.005125:0.008104:0.006410:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188
trial evidence, given the potency, simplicity, and safety :@0.519045:0.602410:0.927970:0.602410:0.927970:0.586627:0.519045:0.586627:0.005125:0.004551:0.003024:0.010326:0.003024:0.004203:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004188:0.004203:0.010175:0.003024:0.008376:0.009827:0.009223:0.004203:0.005125:0.009223:0.009827:0.004203:0.010311:0.009903:0.005125:0.009827:0.009223:0.009782:0.008104:0.004188:0.004203:0.005866:0.003024:0.014182:0.010311:0.003024:0.003024:0.009782:0.003024:0.005125:0.008104:0.004188:0.004218:0.010326:0.009223:0.010357:0.004203:0.005866:0.010326:0.004747:0.009827:0.005125:0.008104:0.004188
table 2. Acute and chronic toxicities:@0.077030:0.632992:0.343428:0.632992:0.343428:0.616493:0.077030:0.616493:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.011188:0.009676:0.009071:0.004536:0.009676:0.004233:0.009979:0.009071:0.009979:0.004233:0.009676:0.009071:0.004838:0.009676:0.009071:0.003629:0.009676:0.004233:0.004536:0.009676:0.008467:0.003629:0.009676:0.003629:0.004536:0.003629:0.009676:0.006652
Anaemia:@0.082070:0.651840:0.142277:0.651840:0.142277:0.637175:0.082070:0.637175:0.009945:0.008063:0.008870:0.008601:0.012633:0.003225:0.008870
5,10:@0.142277:0.647130:0.157391:0.647130:0.157391:0.638993:0.142277:0.638993:0.004318:0.002159:0.004318:0.004318
• :@0.082070:0.666341:0.091612:0.666341:0.091612:0.653770:0.082070:0.653770:0.006182:0.003360
A macrocytosis is common with d4T and AZT. :@0.112308:0.667234:0.406760:0.667234:0.406760:0.653205:0.112308:0.653205:0.009945:0.003723:0.012606:0.009179:0.008695:0.004045:0.008803:0.008695:0.007203:0.004556:0.008803:0.005214:0.002688:0.005214:0.003723:0.002688:0.005214:0.003723:0.008695:0.008803:0.012606:0.012606:0.008803:0.008198:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.009206:0.007445:0.005725:0.003723:0.009179:0.008198:0.009206:0.003723:0.009945:0.006451:0.005725:0.003723:0.003723
• :@0.082070:0.679170:0.091612:0.679170:0.091612:0.666598:0.082070:0.666598:0.006182:0.003360
AZT can cause an anaemia.:@0.112308:0.680062:0.296250:0.680062:0.296250:0.666033:0.112308:0.666033:0.009945:0.006451:0.005725:0.003723:0.008695:0.009179:0.008198:0.003723:0.008695:0.009179:0.008171:0.005214:0.008735:0.003723:0.009179:0.008198:0.003723:0.009179:0.008198:0.009179:0.008735:0.012606:0.002688:0.009179:0.003723
• :@0.082070:0.691998:0.091612:0.691998:0.091612:0.679426:0.082070:0.679426:0.006182:0.003360
3TC and FTC have been associated with a pure red cell aplasia (pRCA). parvovirus B19 infection-induced pRCA should be :@0.112308:0.692891:0.906266:0.692891:0.906266:0.678862:0.112308:0.678862:0.007445:0.005725:0.010926:0.003723:0.009179:0.008198:0.009206:0.003723:0.006518:0.005725:0.010926:0.003723:0.008198:0.009179:0.007445:0.008735:0.003723:0.009165:0.008735:0.008735:0.008198:0.003723:0.009179:0.005214:0.005214:0.008803:0.008695:0.002688:0.009179:0.004556:0.008735:0.009206:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.009179:0.003723:0.009165:0.008171:0.004045:0.008735:0.003723:0.004045:0.008735:0.009206:0.003723:0.008695:0.008735:0.002688:0.002688:0.003723:0.009179:0.009165:0.002688:0.009179:0.005214:0.002688:0.009179:0.003723:0.004959:0.007956:0.008158:0.010926:0.009945:0.004959:0.003723:0.003723:0.007956:0.009179:0.004045:0.007445:0.008803:0.007445:0.002688:0.004045:0.008171:0.005214:0.003723:0.007714:0.007445:0.007445:0.003723:0.002688:0.008198:0.004220:0.008735:0.008695:0.004556:0.002688:0.008803:0.008198:0.004462:0.002688:0.008198:0.009206:0.008171:0.008695:0.008735:0.009206:0.003723:0.007956:0.008158:0.010926:0.009945:0.003723:0.005214:0.008198:0.008803:0.008171:0.002688:0.009206:0.003723:0.009165:0.008735:0.003723
excluded by a pCR test.:@0.112308:0.705719:0.268457:0.705719:0.268457:0.691690:0.112308:0.691690:0.008735:0.006451:0.008695:0.002688:0.008171:0.009206:0.008735:0.009206:0.003723:0.009165:0.007203:0.003723:0.009179:0.003723:0.007956:0.010926:0.008158:0.003723:0.004556:0.008735:0.005214:0.004556:0.003723
Dysglycaemia:@0.082070:0.721113:0.175875:0.721113:0.175875:0.706448:0.082070:0.706448:0.009407:0.007795:0.005913:0.008870:0.003225:0.007795:0.008601:0.008870:0.008601:0.012633:0.003225:0.008870
5,11:@0.175882:0.716403:0.190996:0.716403:0.190996:0.708266:0.175882:0.708266:0.004318:0.002159:0.004318:0.004318
• :@0.082070:0.735614:0.091612:0.735614:0.091612:0.723042:0.082070:0.723042:0.006182:0.003360
Visceral fat gain, which occurs to a similar extent with all ART classes, is associated with insulin resistance.:@0.112308:0.736507:0.788969:0.736507:0.788969:0.722478:0.112308:0.722478:0.009434:0.002688:0.005214:0.008695:0.008735:0.004045:0.009179:0.002688:0.003723:0.004220:0.009179:0.004556:0.003723:0.009045:0.009179:0.002688:0.008198:0.003723:0.003723:0.011168:0.008198:0.002688:0.008695:0.008198:0.003723:0.008803:0.008695:0.008695:0.008171:0.004045:0.005214:0.003723:0.004556:0.008803:0.003723:0.009179:0.003723:0.005214:0.002688:0.012606:0.002688:0.002688:0.009179:0.004045:0.003723:0.008735:0.006451:0.004556:0.008735:0.008198:0.004556:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.009179:0.002688:0.002688:0.003723:0.009945:0.008158:0.005725:0.003723:0.008695:0.002688:0.009179:0.005214:0.005214:0.008735:0.005214:0.003723:0.003723:0.002688:0.005214:0.003723:0.009179:0.005214:0.005214:0.008803:0.008695:0.002688:0.009179:0.004556:0.008735:0.009206:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.002688:0.008198:0.005214:0.008171:0.002688:0.002688:0.008198:0.003723:0.004045:0.008735:0.005214:0.002688:0.005214:0.004556:0.009179:0.008198:0.008695:0.008735:0.003723
• :@0.082070:0.748442:0.091612:0.748442:0.091612:0.735871:0.082070:0.735871:0.006182:0.003360
Blood glucose should be assessed as part of a cardiovascular-risk assessment.:@0.112308:0.749335:0.615510:0.749335:0.615510:0.735306:0.112308:0.735306:0.007714:0.002688:0.008803:0.008803:0.009206:0.003723:0.009045:0.002688:0.008171:0.008695:0.008803:0.005214:0.008735:0.003723:0.005214:0.008198:0.008803:0.008171:0.002688:0.009206:0.003723:0.009165:0.008735:0.003723:0.009179:0.005214:0.005214:0.008735:0.005214:0.005214:0.008735:0.009206:0.003723:0.009179:0.005214:0.003723:0.009165:0.009179:0.004045:0.004556:0.003723:0.008803:0.004220:0.003723:0.009179:0.003723:0.008695:0.009179:0.004045:0.009206:0.002688:0.008803:0.007445:0.009179:0.005214:0.008695:0.008171:0.002688:0.009179:0.004045:0.004462:0.004045:0.002688:0.005214:0.006746:0.003723:0.009179:0.005214:0.005214:0.008735:0.005214:0.005214:0.012606:0.008735:0.008198:0.004556:0.003723
Dyslipidaemia:@0.082070:0.764729:0.174800:0.764729:0.174800:0.750064:0.082070:0.750064:0.009407:0.007795:0.005913:0.003225:0.003225:0.008870:0.003225:0.008870:0.008870:0.008601:0.012633:0.003225:0.008870
5,11 :@0.174799:0.760019:0.192072:0.760019:0.192072:0.751882:0.174799:0.751882:0.004318:0.002159:0.004318:0.004318:0.002159
• :@0.082070:0.779230:0.091612:0.779230:0.091612:0.766658:0.082070:0.766658:0.006182:0.003360
Associated with all classes. All pIs with the exception of unboosted ATV can cause fasting hypertriglyceridaemia and :@0.112308:0.780123:0.871364:0.780123:0.871364:0.766094:0.112308:0.766094:0.009945:0.005214:0.005214:0.008803:0.008695:0.002688:0.009179:0.004556:0.008735:0.009206:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.009179:0.002688:0.002688:0.003723:0.008695:0.002688:0.009179:0.005214:0.005214:0.008735:0.005214:0.003723:0.003723:0.009945:0.002688:0.002688:0.003723:0.007956:0.003037:0.005214:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.004556:0.008198:0.008735:0.003723:0.008735:0.006451:0.008695:0.008735:0.009165:0.004556:0.002688:0.008803:0.008198:0.003723:0.008803:0.004220:0.003723:0.008171:0.008198:0.009165:0.008803:0.008803:0.005214:0.004556:0.008735:0.009206:0.003723:0.009945:0.005725:0.009434:0.003723:0.008695:0.009179:0.008198:0.003723:0.008695:0.009179:0.008171:0.005214:0.008735:0.003723:0.004220:0.009179:0.005214:0.004556:0.002688:0.008198:0.009045:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.004045:0.002688:0.009045:0.002688:0.007203:0.008695:0.008735:0.004045:0.002688:0.009206:0.009179:0.008735:0.012606:0.002688:0.009179:0.003723:0.009179:0.008198:0.009206:0.003723
elevated LDL-cholesterol. d4T can cause mild hypertriglyceridaemia. EFV can cause elevated total cholesterol and mild :@0.112308:0.792951:0.895084:0.792951:0.895084:0.778922:0.112308:0.778922:0.008735:0.002688:0.008735:0.007445:0.009179:0.004556:0.008735:0.009206:0.003723:0.006209:0.009999:0.006209:0.004462:0.008695:0.008198:0.008803:0.002688:0.008735:0.005214:0.004556:0.008735:0.004045:0.008803:0.002688:0.003723:0.003723:0.009206:0.007445:0.005725:0.003723:0.008695:0.009179:0.008198:0.003723:0.008695:0.009179:0.008171:0.005214:0.008735:0.003723:0.012606:0.002688:0.002688:0.009206:0.003723:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.004045:0.002688:0.009045:0.002688:0.007203:0.008695:0.008735:0.004045:0.002688:0.009206:0.009179:0.008735:0.012606:0.002688:0.009179:0.003723:0.003723:0.007203:0.006518:0.009434:0.003723:0.008695:0.009179:0.008198:0.003723:0.008695:0.009179:0.008171:0.005214:0.008735:0.003723:0.008735:0.002688:0.008735:0.007445:0.009179:0.004556:0.008735:0.009206:0.003723:0.004556:0.008803:0.004556:0.009179:0.002688:0.003723:0.008695:0.008198:0.008803:0.002688:0.008735:0.005214:0.004556:0.008735:0.004045:0.008803:0.002688:0.003723:0.009179:0.008198:0.009206:0.003723:0.012606:0.002688:0.002688:0.009206:0.003723
hypertriglyceridaemia.:@0.112308:0.805780:0.259359:0.805780:0.259359:0.791751:0.112308:0.791751:0.008198:0.007203:0.009165:0.008735:0.004045:0.004556:0.004045:0.002688:0.009045:0.002688:0.007203:0.008695:0.008735:0.004045:0.002688:0.009206:0.009179:0.008735:0.012606:0.002688:0.009179:0.003723
• :@0.082070:0.817715:0.091612:0.817715:0.091612:0.805143:0.082070:0.805143:0.006182:0.003360
Indications for statin therapy in a HIV-infected patient should be the same as in an uninfected patient, but if the patient is :@0.112308:0.818608:0.903027:0.818608:0.903027:0.804579:0.112308:0.804579:0.003037:0.008198:0.009206:0.002688:0.008695:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723:0.004220:0.008803:0.004045:0.003723:0.005214:0.004556:0.009179:0.004556:0.002688:0.008198:0.003723:0.004556:0.008198:0.008735:0.004045:0.009179:0.009165:0.007203:0.003723:0.002688:0.008198:0.003723:0.009179:0.003723:0.009179:0.003037:0.009434:0.004462:0.002688:0.008198:0.004220:0.008735:0.008695:0.004556:0.008735:0.009206:0.003723:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.003723:0.005214:0.008198:0.008803:0.008171:0.002688:0.009206:0.003723:0.009165:0.008735:0.003723:0.004556:0.008198:0.008735:0.003723:0.005214:0.009179:0.012606:0.008735:0.003723:0.009179:0.005214:0.003723:0.002688:0.008198:0.003723:0.009179:0.008198:0.003723:0.008171:0.008198:0.002688:0.008198:0.004220:0.008735:0.008695:0.004556:0.008735:0.009206:0.003723:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.003723:0.003723:0.009165:0.008171:0.004556:0.003723:0.002688:0.004220:0.003723:0.004556:0.008198:0.008735:0.003723:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.003723:0.002688:0.005214:0.003723
receiving a pI, a switch to boosted ATV is a better option, rather than adding therapy for the dyslipidaemia. switching the pI :@0.112308:0.831436:0.918455:0.831436:0.918455:0.817407:0.112308:0.817407:0.004045:0.008735:0.008695:0.008735:0.002688:0.007445:0.002688:0.008198:0.009045:0.003723:0.009179:0.003723:0.007956:0.003037:0.003723:0.003723:0.009179:0.003723:0.005214:0.011168:0.002688:0.004556:0.008695:0.008198:0.003723:0.004556:0.008803:0.003723:0.009165:0.008803:0.008803:0.005214:0.004556:0.008735:0.009206:0.003723:0.009945:0.005725:0.009434:0.003723:0.002688:0.005214:0.003723:0.009179:0.003723:0.009165:0.008735:0.004556:0.004556:0.008735:0.004045:0.003723:0.008803:0.009165:0.004556:0.002688:0.008803:0.008198:0.003723:0.003723:0.004045:0.009179:0.004556:0.008198:0.008735:0.004045:0.003723:0.004556:0.008198:0.009179:0.008198:0.003723:0.009179:0.009206:0.009206:0.002688:0.008198:0.009045:0.003723:0.004556:0.008198:0.008735:0.004045:0.009179:0.009165:0.007203:0.003723:0.004220:0.008803:0.004045:0.003723:0.004556:0.008198:0.008735:0.003723:0.009206:0.007203:0.005214:0.002688:0.002688:0.009165:0.002688:0.009206:0.009179:0.008735:0.012606:0.002688:0.009179:0.003723:0.003723:0.006693:0.011168:0.002688:0.004556:0.008695:0.008198:0.002688:0.008198:0.009045:0.003723:0.004556:0.008198:0.008735:0.003723:0.007956:0.003037:0.003723
to RAL is another option, but only if used in a regimen with two other fully active drugs.:@0.112308:0.844264:0.671094:0.844264:0.671094:0.830235:0.112308:0.830235:0.004556:0.008803:0.003723:0.008158:0.009945:0.006209:0.003723:0.002688:0.005214:0.003723:0.009179:0.008198:0.008803:0.004556:0.008198:0.008735:0.004045:0.003723:0.008803:0.009165:0.004556:0.002688:0.008803:0.008198:0.003723:0.003723:0.009165:0.008171:0.004556:0.003723:0.008803:0.008198:0.002688:0.007203:0.003723:0.002688:0.004220:0.003723:0.008171:0.005214:0.008735:0.009206:0.003723:0.002688:0.008198:0.003723:0.009179:0.003723:0.004045:0.008735:0.009045:0.002688:0.012606:0.008735:0.008198:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.004556:0.011168:0.008803:0.003723:0.008803:0.004556:0.008198:0.008735:0.004045:0.003723:0.004220:0.008171:0.002688:0.002688:0.007203:0.003723:0.009179:0.008695:0.004556:0.002688:0.007445:0.008735:0.003723:0.009206:0.004045:0.008171:0.009045:0.005214:0.003723
• :@0.082070:0.856200:0.091612:0.856200:0.091612:0.843628:0.082070:0.843628:0.006182:0.003360
Statins have interactions with PIs that can lead to toxic concentrations, except pravastatin and fluvastatin. Atorvastatin :@0.112308:0.857093:0.888204:0.857093:0.888204:0.843064:0.112308:0.843064:0.006693:0.004556:0.009179:0.004556:0.002688:0.008198:0.005214:0.003723:0.008198:0.009179:0.007445:0.008735:0.003723:0.002688:0.008198:0.004556:0.008735:0.004045:0.009179:0.008695:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.007956:0.003037:0.005214:0.003723:0.004556:0.008198:0.009179:0.004556:0.003723:0.008695:0.009179:0.008198:0.003723:0.002688:0.008735:0.009179:0.009206:0.003723:0.004556:0.008803:0.003723:0.004556:0.008803:0.006451:0.002688:0.008695:0.003723:0.008695:0.008803:0.008198:0.008695:0.008735:0.008198:0.004556:0.004045:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723:0.003723:0.008735:0.006451:0.008695:0.008735:0.009165:0.004556:0.003723:0.009165:0.004045:0.009179:0.007445:0.009179:0.005214:0.004556:0.009179:0.004556:0.002688:0.008198:0.003723:0.009179:0.008198:0.009206:0.003723:0.003259:0.003259:0.008171:0.007445:0.009179:0.005214:0.004556:0.009179:0.004556:0.002688:0.008198:0.003723:0.003723:0.009945:0.004556:0.008803:0.004045:0.007445:0.009179:0.005214:0.004556:0.009179:0.004556:0.002688:0.008198:0.003723
concentrations are significantly raised by PIs, but lower doses of 10 mg daily may be used. Lovastatin and simvastatin should :@0.112308:0.869921:0.920928:0.869921:0.920928:0.855892:0.112308:0.855892:0.008695:0.008803:0.008198:0.008695:0.008735:0.008198:0.004556:0.004045:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723:0.009179:0.004045:0.008735:0.003723:0.005214:0.002688:0.009045:0.008198:0.002688:0.003272:0.003272:0.008695:0.009179:0.008198:0.004556:0.002688:0.007203:0.003723:0.004045:0.009179:0.002688:0.005214:0.008735:0.009206:0.003723:0.009165:0.007203:0.003723:0.007956:0.003037:0.005214:0.003723:0.003723:0.009165:0.008171:0.004556:0.003723:0.002688:0.008803:0.011168:0.008735:0.004045:0.003723:0.009206:0.008803:0.005214:0.008735:0.005214:0.003723:0.008803:0.004220:0.003723:0.007445:0.007445:0.003723:0.012606:0.009045:0.003723:0.009206:0.009179:0.002688:0.002688:0.007203:0.003723:0.012606:0.009179:0.007203:0.003723:0.009165:0.008735:0.003723:0.008171:0.005214:0.008735:0.009206:0.003723:0.003723:0.006209:0.008803:0.007445:0.009179:0.005214:0.004556:0.009179:0.004556:0.002688:0.008198:0.003723:0.009179:0.008198:0.009206:0.003723:0.005214:0.002688:0.012606:0.007445:0.009179:0.005214:0.004556:0.009179:0.004556:0.002688:0.008198:0.003723:0.005214:0.008198:0.008803:0.008171:0.002688:0.009206:0.003723
not be used as a severe rhabdomyolysis can occur.:@0.112308:0.882749:0.447776:0.882749:0.447776:0.868720:0.112308:0.868720:0.008198:0.008803:0.004556:0.003723:0.009165:0.008735:0.003723:0.008171:0.005214:0.008735:0.009206:0.003723:0.009179:0.005214:0.003723:0.009179:0.003723:0.005214:0.008735:0.007445:0.008735:0.004045:0.008735:0.003723:0.004045:0.008198:0.009179:0.009165:0.009206:0.008803:0.012606:0.007203:0.008803:0.002688:0.007203:0.005214:0.002688:0.005214:0.003723:0.008695:0.009179:0.008198:0.003723:0.008803:0.008695:0.008695:0.008171:0.004045:0.003723
Gynaecomastia:@0.082070:0.898143:0.187433:0.898143:0.187433:0.883478:0.082070:0.883478:0.011289:0.007795:0.008063:0.008870:0.008601:0.008601:0.008601:0.012633:0.008870:0.005913:0.004032:0.003225:0.008870
5,11:@0.187437:0.893433:0.202551:0.893433:0.202551:0.885296:0.187437:0.885296:0.004318:0.002159:0.004318:0.004318
• :@0.082070:0.912644:0.091612:0.912644:0.091612:0.900072:0.082070:0.900072:0.006182:0.003360
Bilateral or unilateral development of breast tissue in men. :@0.112308:0.913537:0.491776:0.913537:0.491776:0.899508:0.112308:0.899508:0.007714:0.002688:0.002688:0.009179:0.004556:0.008735:0.004045:0.009179:0.002688:0.003723:0.008803:0.004045:0.003723:0.008171:0.008198:0.002688:0.002688:0.009179:0.004556:0.008735:0.004045:0.009179:0.002688:0.003723:0.009206:0.008735:0.007445:0.008735:0.002688:0.008803:0.009165:0.012606:0.008735:0.008198:0.004556:0.003723:0.008803:0.004220:0.003723:0.009165:0.004045:0.008735:0.009179:0.005214:0.004556:0.003723:0.004556:0.002688:0.005214:0.005214:0.008171:0.008735:0.003723:0.002688:0.008198:0.003723:0.012606:0.008735:0.008198:0.003723:0.003723
• :@0.082070:0.925472:0.091612:0.925472:0.091612:0.912901:0.082070:0.912901:0.006182:0.003360
Not related to lipodystrophy. :@0.112308:0.926365:0.301666:0.926365:0.301666:0.912336:0.112308:0.912336:0.009945:0.008803:0.004556:0.003723:0.004045:0.008735:0.002688:0.009179:0.004556:0.008735:0.009206:0.003723:0.004556:0.008803:0.003723:0.002688:0.002688:0.009165:0.008803:0.009206:0.007203:0.005214:0.004556:0.004045:0.008803:0.009165:0.008198:0.007203:0.003723:0.003723
• :@0.082070:0.938301:0.091612:0.938301:0.091612:0.925729:0.082070:0.925729:0.006182:0.003360
Associated with EFV, so patients should be switched to either NVP (only if CD4 <400), a PI or an InSTI:@0.112308:0.939194:0.754739:0.939194:0.754739:0.925165:0.112308:0.925165:0.009945:0.005214:0.005214:0.008803:0.008695:0.002688:0.009179:0.004556:0.008735:0.009206:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.007203:0.006518:0.009434:0.003723:0.003723:0.005214:0.008803:0.003723:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.005214:0.003723:0.005214:0.008198:0.008803:0.008171:0.002688:0.009206:0.003723:0.009165:0.008735:0.003723:0.005214:0.011168:0.002688:0.004556:0.008695:0.008198:0.008735:0.009206:0.003723:0.004556:0.008803:0.003723:0.008735:0.002688:0.004556:0.008198:0.008735:0.004045:0.003723:0.009945:0.009434:0.007956:0.003723:0.004959:0.008803:0.008198:0.002688:0.007203:0.003723:0.002688:0.004220:0.003723:0.010926:0.009999:0.007445:0.003723:0.008144:0.007445:0.007445:0.007445:0.004959:0.003723:0.003723:0.009179:0.003723:0.007956:0.003037:0.003723:0.008803:0.004045:0.003723:0.009179:0.008198:0.003723:0.003037:0.008198:0.006693:0.005725:0.003037